Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent by Selvaraj, Ahalya & Prywes, Ron
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Molecular Biology
Open Access Research article
Expression profiling of serum inducible genes identifies a subset of 
SRF target genes that are MKL dependent
Ahalya Selvaraj and Ron Prywes*
Address: Department of Biological Sciences, Columbia University, New York, New York, USA
Email: Ahalya Selvaraj - as814@columbia.edu; Ron Prywes* - mrp6@columbia.edu
* Corresponding author    
Abstract
Background: Serum Response Factor (SRF) is a transcription factor that is required for the
expression of many genes including immediate early genes, cytoskeletal genes, and muscle-specific
genes. SRF is activated in response to extra-cellular signals by its association with a diverse set of
co-activators in different cell types. In the case of the ubiquitously expressed immediate early genes,
the two sets of SRF binding proteins that regulate its activity are the TCF family of proteins that
include Elk1, SAP1 and SAP2 and the myocardin-related MKL family of proteins that include MKL1
and MKL2 (also known as MAL, MRTF-A and -B and BSAC). In response to serum or growth
factors these two classes of co-activators are activated by different upstream signal transduction
pathways. However, it is not clear how they differentially activate SRF target genes.
Results: In order to identify the serum-inducible SRF target genes that are specifically dependent
on the MKL pathway, we have performed microarray experiments using a cell line that expresses
dominant negative MKL1. This approach was used to identify SRF target genes whose activation is
MKL-dependent. Twenty-eight of 150 serum-inducible genes were found to be MKL-dependent.
The promoters of the serum-inducible genes were analyzed for SRF binding sites and other
common regulatory elements. Putative SRF binding sites were found at a higher rate than in a
mouse promoter database but were only identified in 12% of the serum-inducible promoters
analyzed. Additional partial matches to the consensus SRF binding site were found at a higher than
expected rate in the MKL-dependent gene promoters. The analysis for other common regulatory
elements is discussed.
Conclusions: These results suggest that a subset of immediate early and SRF target genes are
activated by the Rho-MKL pathway. MKL may also contribute to the induction of other SRF target
genes however its role is not essential, possibly due to other activation mechanisms such as MAPK
phosphorylation of TCFs.
Background
Quiescent cells exposed to growth factors respond by
expressing a variety of immediate early genes (IEG) that
do not need new protein synthesis for their expression [1].
Serum or growth factor induced expression of many of
these immediate early genes, such as c-fos, egr1, cyr61 and
pip92, is dependent on a sequence element in their pro-
moter termed the Serum Response Element (SRE). This
sequence element contains an A/T rich core flanked by an
inverted repeat and is also known as the CArG box (CC(A/
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T)6GG). The CArG box is specifically bound by Serum
Response Factor (SRF) [2-4]. Both the SRE and SRF are
required for the serum inducibility of these genes since
microinjection of SRE oligonucleotides or anti-SRF anti-
bodies blocked induction in NIH3T3 cells [5]. In addi-
tion, mutation of the SRE blocked serum induction of
reporter genes containing immediate early gene promot-
ers and SRF null ES cells were defective for immediate
early gene activation [6,7].
Although the immediate early genes are so named because
of their rapid inducibility after growth factor treatment,
different kinetics of expression have been observed
among the immediate early genes. Expression of the
proto-oncogene c-fos peaks at around 30 minutes after
stimulation whereas the peak expression of SRF mRNA
occurs after 90–120 minutes [8,9]. Thus SRF has been
characterized as a "delayed" IEG although its expression is
still independent of new protein synthesis.
Activation of SRF by growth factors occurs through at least
two mechanisms – the TCF and RhoA pathways [10,11].
Serum or growth factor induction leads to the phosphor-
ylation of p62TCF by MAP kinases. TCF is a ternary com-
plex factor that binds to both SRF and flanking sequences
of the SRE. TCF binding to the SRE requires the prior bind-
ing of SRF as well as an adjacent TCF binding site. TCF is
encoded by three ets-related genes, Elk1, SAP1 and SAP2/
Net [12].
An additional pathway that activates SRF is through acti-
vation of the small GTPase RhoA [11]. Activated RhoA
induces the expression of SRE reporter genes while inhibi-
tion of RhoA blocks serum induction. RhoA also causes
the formation of stress fibers and the use of actin filament
inhibitors and actin mutants suggests that actin treadmill-
ing can control SRE activation [13,14]. The RhoA effectors
mDia and ROCK appear to be involved in regulating both
actin treadmilling and SRF activation [15,16]. This has led
to a model whereby free G-actin inhibits SRF activation
and this inhibition is relieved when G-actin levels are
depleted by their polymerization into actin filaments.
However, mutants of RhoA have been identified that are
defective for SRF activation but still cause the formation of
stress fibers and vice versa, suggesting that a pathway
exists for RhoA activation of SRF independent of stress
fiber formation [17,18].
The use of pathway specific inhibitors has suggested the
presence of two types of SRF target genes – those that are
largely dependent on the Rho-actin pathway and those
that are largely dependent on the MAP kinase pathway
[19]. Use of reporter genes suggests that some promoters
may be activated by both pathways, but that activation by
the Rho pathway is only apparent after mutation of the
TCF pathway [20].
We and others have recently identified a family of SRF-
specific transcriptional co-activators – the MKL family,
comprised of MKL1 and MKL2, that function downstream
of the RhoA pathway [21-26]. MKL1 and 2 are widely
expressed genes related to the heart and smooth muscle-
specific SRF co-activator myocardin [21,22,24-29], thus
making them candidate proteins in the signal transduc-
tion pathway of immediate early genes. Indeed, experi-
ments using dominant negative proteins and RNA
interference have shown that they are required for the
induction of the immediate early genes srf, vinculin and c-
fos [21,23]. Serum induction of SRF and vinculin was
dependent on MKL1 both at the early and late time points
of induction, while serum induction of c-fos showed a
modest MKL-dependence at the later time points of serum
induction and was largely independent of MKL at the
early time points of induction (30 minutes) [21]. Consist-
ent with this, Gineitis et al. identified c-fos as a gene
whose serum induction is largely dependent on the
MAPK-TCF pathway [19]. Overexpression of MKL1 has
different effects on specific SRF target gene promoters, as
some were strongly activated (e.g. smooth muscle α-actin,
SM22) while others were poorly induced (e.g. c-fos, egr-
1)[21]. The lower activation of the c-fos promoter is not
due to the c-fos SRE per se, since reporter genes containing
the c-fos SRE on a minimal promoter were strongly acti-
vated by MKL1 [21,27].
Chromatin immunoprecipitation experiments have
shown that MKL1 binds to the promoters of the cyr61, srf
and vinculin genes but not egr-1 or c-fos after swinholide
treatment which leads to the activation of the Rho-actin
pathway [23]. Moreover SAP-1 (a TCF factor) bound to
the egr-1 promoter but not to the srf, vinculin or cyr61
promoters suggesting that TCF and MKL1 binding to tar-
get promoters might be mutually exclusive. Indeed, in
vitro gel mobility shift assays suggest that MKL1 and Elk-
1 bind to the same region of SRF [23]. Nevertheless, it is
still unclear how MKL family factors distinguish SRF target
genes. It is possible that there are specific CArG box
sequences, that TCF sites adjacent to SREs inhibit activa-
tion or that other flanking elements control sensitivity to
MKL activation.
As a first step towards a better understanding of this differ-
ential target gene selection and to demonstrate the impor-
tance of the MKL coactivators in immediate early gene
induction, we sought to identify the group of SRF target
genes that were dependent on the RhoA-MKL pathway.
We performed microarray analysis using cell lines express-
ing dominant negative MKL1 (DN-MKL1) to identify
MKL-dependent and -independent serum-induced SRFBMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
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target genes. The DN-MKL1 protein is effective in blocking
both MKL1 and 2 activation of SREs, thus solving the
problem of redundancy of these proteins in the cell
[21,24](unpublished data). As a control, DN-MKL1 did
not affect TCF-pathway induction of reporter genes [21].
Hence, cell lines expressing DN-MKL1 can be used to elu-
cidate the target genes of SRF that require MKL1/2 for their
activation. We have further searched the target promoters
for common regulatory elements, in particular for perfect
or variant CArG box sequences to identify promoters that
are more likely to be direct targets of SRF-MKL activity.
Results
Dominant negative MKL1 inhibits serum induction of SRF 
target genes
We have utilized a C-terminal deletion mutant of MKL1
(a.a. 1-630) as a dominant negative mutant. We previ-
ously found that this mutant can prevent activation of SRE
reporter genes by MKL1 and MKL2 overexpression
[21](unpublished data). This DN-MKL1 mutant can bind
to SRF but lacks a transcriptional activation domain.
Expression of DN-MKL1 reduced serum induction of a c-
fos reporter gene that lacks a TCF site and strongly blocked
RhoA activation of this reporter [21]. We generated a cell
line stably expressing DN-MKL1 in NIH3T3 cells in order
to more easily look at its effect on endogenous gene
expression. We found a strong effect on serum-induced
expression of the known SRF target genes vinculin and the
SRF gene itself [21]. However, binding of dominant nega-
tive MKL1 to SRF could titrate other SRF complexing pro-
teins such as the TCF factors Elk1 and SAP-1/2, since they
all bind to the MADS box DNA binding domain of SRF
[23]. Thus there is a possibility that DN-MKL1 could
block the serum induced expression of target genes by
indirectly blocking the TCF pathway. We previously found
that dominant negative MKL1 does not significantly
inhibit tetradecanoyl phorbol acetate (TPA) activation of
SRE reporter genes, which functions through MAPK phos-
phorylation of TCF [12,21]. We sought to further confirm
this for endogenous gene targets. Serum starved cells were
induced with serum or TPA for 60 minutes and the mRNA
from these cells were assayed for the expression of the
endogenous target genes c-fos and junB by real-time PCR
(Fig. 1). The DN-MKL1 cell line showed a modest decrease
in serum induced expression of c-fos, consistent with our
previous RNase protection measurements [21]. A larger
decrease was observed for serum induction of junB, how-
ever there was no significant change in TPA induced
expression of either c-fos or c-jun in the DN-MKL1 cell
line (Fig. 1). Hence, DN-MKL1 does not block the TCF
pathway and effectively distinguishes the MKL and TCF
pathways.
Microarray analysis identifies MKL dependent genes with 
varying kinetics of expression
In order to more fully characterize the temporal program
of serum induced gene expression and the role of MKL, we
performed microarray analysis on wt and DN-MKL1
NIH3T3 cells that had been serum-starved and induced
with serum for 0, 30, 60 or 120 minutes. These times
should distinguish early vs. 'delayed' immediate early
genes. Mouse Affymetrix oligonucleotide arrays
(MOE430A) containing 14,824 non-redundant probes
were used for hybridization. All data points were done in
triplicate and hierarchical clustering was performed using
dChip software analysis. We found 229 genes that showed
a significant variation across the 8 samples and used the
results with these genes for unsupervised clustering [30].
The hierarchical clustering analysis shows classes of differ-
entially regulated genes which we have designated classes
1 to 10 (Fig. 2). We were particularly interested in serum-
induced genes. However, one class was constitutively
repressed in DN-MKL1 cells (#1) and another was consti-
tutively activated (#5). Further, one class was repressed by
serum induction (#4) though there was no significant
effect of DN-MKL1. This leaves seven classes of genes that
are serum-induced with different kinetics and dependency
upon MKL1. Classes 2, 3 and 8 were induced early at the
30 minute time point while classes 6 and 7 had maximal
induction at 120 minutes. Classes 9 and 10 had peak
induction at the intermediate time point of 60 minutes.
Serum induced expression of classes 2, 7 and 9 as well as
many of the genes in class 8 were particularly MKL-
dependent while the other serum-induced genes (classes
3, 6 and 10) were predominantly MKL-independent. The
positions of known SRF target genes that we previously
studied are indicated (Fig. 2). The vinculin and srf genes
fall into the MKL-dependent classes 7 and 9 consistent
with our previous results [21]. Serum-induced expression
of the c-fos gene was predominantly independent of
MKL1.
To analyze the serum-inducible genes more carefully, we
further dissected the data using more stringent criteria to
identify MKL-dependent genes at each time point. We fil-
tered for genes that were serum-induced ≥ 2 fold in WT
cells and whose expression in DN-MKL1 cells was at least
35% less than in WT cells (Tables 1, 2 and 3). We picked
points that fell within the 90% confidence intervals for
both fold serum induction and decrease in DN-MKL1
cells. At the 30 minute time point, 12 out of the 52 serum-
inducible genes were MKL dependent. Similarly, 6 out of
59 and 18 out of 123 genes were MKL dependent at the 60
and 120 minute time points, respectively. The genes pre-
viously shown to contain SRF binding sites are indicated.
Consolidating these results to eliminate multiple listings
of genes induced at different time points, we haveBMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
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identified 28 out of 150 serum-inducible genes as MKL-
dependent (Table 4). A list of the 122 serum inducible,
MKL-independent genes is shown in the supplemental
table.
Correlation of microarray and real time PCR data
To verify the results obtained from the microarray experi-
ments, we checked seven genes by real time quantitative
PCR using the SYBR Green method. There was a good, but
not perfect correlation, of these methods (Fig. 3). Four
MKL-dependent genes, jun B, srf, interleukin 6 and epireg-
ulin, were also found to be MKL-dependent by real time
PCR. Similarly, two MKL-independent genes, cyr61 and
egr-1, were also MKL-independent by real time PCR.
Finally, c-fos expression was only moderately reduced in
DN-MKL1 cells whether measured by microarray or real
time PCR (Fig. 3G). This inhibition was not high enough
to meet the cut-off of 35% reduction for our list of MKL-
dependent genes (Fig. 4). This result contrasts somewhat
with our measurements of c-fos mRNA by RNase protec-
tion. We previously found that c-fos mRNA was signifi-
cantly reduced in DN-MKL1 cells at the 60 minute time
point, though not the 30 minute point. Since there was
inhibition noted by each method, this difference may
reflect the sensitivity of each method to detect precise
changes in expression. There were also some differences
between the microarray and real time PCR results such as
inhibition of Jun B expression at the 30 minute point by
the PCR method but not by microarray (Fig. 3A) and the
greater serum induction of egr-1 mRNA measured by real
Effect of serum and TPA on gene expression in WT and DN-MKL1 cell lines. Figure 1
Effect of serum and TPA on gene expression in WT and DN-MKL1 cell lines. Serum starved cells were treated with 
new born calf serum (20%) or TPA (100 ng/ml) for 1 hour and relative mRNA levels for c-fos and jun B were measured by 
quantitative real-time PCR using the SYBR green method. Data are represented as the relative fold activation ± the standard 
deviation of the induced cells compared to the serum starved WT cells.
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Hierarchical clustering of gene expression Figure 2
Hierarchical clustering of gene expression. RNA from WT and DN-MKL1 expressing cells induced with serum for the 
indicated times was used to probe an Affymetrix mouse chip with 14,824 non-redundant probes. dChip software was used to 
identify genes with significant variation across samples. 229 such genes were used for clustering analysis. Different classes of 
similarly regulated genes are indicated to the right and discussed in the text. The respective positions where the previously 
characterized MKL target genes srf, vinculin and c-fos fall are indicated by the arrows. Expression scales ranging from -3 (blue) 
to +3 (red) fold are indicated at the bottom of the figure.
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Table 1: List of genes induced by serum at 30 minutes in WT cells and reduced in DN-MKL1 cells.
Gene Locus Link Fold change Lower CI Upper CI % decrease in 
DN
known SRE
1 similar to Hs Mitogen inducible 
gene 6
74155 18.67 12.81 26.3 54
2 coagulation factor III 14066 8.05 5.44 14.29 47
3 retinoblastoma inhibiting gene 1 19649 6.45 4.97 8.90 63
4 tropomyosin 1, alpha 22003 5.92 4.18 8.55 63 YES
5 pleckstrin homology-like 
domain
21664 5.82 3.67 11.48 65
6 epiregulin 13874 5.77 3.15 9.27 71
7 leukemia inhibitory factor 16878 4.84 2.79 7.65 57
8 serum response factor 20807 4.7 3.25 6.40 60 YES
9 tribbles homolog 1 211770 3.87 2.81 5.10 50
10 aortic alpha actin-2 68377 3.77 2.94 5.06 52 YES
11 fos-like antigen 1 14283 3.02 2.27 3.89 44 YES
12 CDC42 effector protein 3 260409 2.47 2.19 2.81 46
Table 2: List of genes induced by serum at 60 minutes in WT cells and reduced in DN-MKL1 cells.
Gene Locus Link Fold change Lower CI Upper CI % decrease in 
DN
known SRE
1 serum response factor 20807 6.26 4.66 8.20 59 YES
2 enigma homolog 56376 4.75 3.63 6.28 61
3 adrenomedullin 11535 4.15 3.28 5.17 57
4 retinoblastoma inhibiting gene 1 19649 3.92 2.68 5.75 50
5 CDC42 effector protein 3 260409 3.18 2.40 4.38 48
6 adenosine A2b receptor 11541 2.56 2.00 3.24 40
Table 3: List of genes induced by serum at 120 minutes in WT cells and reduced in DN-MKL1 cells.
Gene Locus Link Fold change Lower CI Upper CI % decrease in 
DN
known SRE
1 leukemia inhibitory factor 16878 32.79 16.31 54.48 82
2 epiregulin 13874 21.48 13.61 32.57 54
3 interleukin 6 16193 7.84 4.11 12.98 90
4 inhibitor of DNA binding 3 15903 7.34 5.86 9.45 51
5 snail homolog 1 20613 6.14 4.17 9.00 55
6 serum response factor 20807 5.83 4.39 7.61 53 YES
7 hexokinase 2 15277 5.43 3.52 7.51 52
8 TGFB inducible early growth 
response
21847 5.39 3.88 7.42 53
9 enigma homolog 56376 5.37 4.26 6.93 57
10 Jun-B oncogene 16477 5.25 3.12 7.93 61 YES
11 vinculin 22330 4.54 3.32 6.10 52 YES
12 expressed sequence AA939927 99526 4.38 3.35 5.79 76
13 B-cell translocation gene 2, anti-
proliferative
12227 3.58 2.34 6.09 63
14 adrenomedullin 11535 3.30 2.79 3.91 47
15 methionine adenosyltransferase 
II, alpha
232087 3.28 2.70 3.95 43
16 ELL-related RNA polymerase II 192657 3.15 2.34 4.56 39
17 zyxin 22793 2.70 2.09 3.37 46
18 transmembrane 4 superfamily 
member 10 homolog
109160 2.32 2.11 2.56 39BMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
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time PCR (Fig. 3F). Nevertheless, the general levels of
induction and DN-MKL1 inhibition were similar by both
methods. This is reflected in the Pearson's correlation
coefficient of 0.92 for a comparison of all of the data
attained by each method shown in Fig. 3. The correlation
coefficient ranged for 0.85 to 0.99 for the data with any
one gene.
Promoter analysis of MKL-dependent and -independent 
serum-inducible genes
We compared the serum inducible genes to known SRF
target genes to identify those genes with SRF binding sites.
Comparing to a list of SRF targets genes [31](J.M. Miano,
personal communication) we found that five of 28 MKL-
dependent genes had known CArG box sites while eight of
122 MKL-independent genes had known sites (Table 4).
We further analyzed the promoters of the MKL-dependent
genes to identify SRF binding sites that would potentially
be direct targets of MKL. Promoter sequences for the
serum inducible MKL-dependent or -independent genes
were extracted from the Database of Transcription Start
Sites (DBTSS) [32]. This database contains exact informa-
tion of the genomic positions of the transcriptional start
sites (based on full length cDNAs) and the adjacent
promoters for 6,875 mouse genes. The upstream sequence
(-1000 to +200 relative to the transcription start site) of
each of the candidate genes was searched for the consen-
sus SRF binding site (CCWWWWWWGG, where W is A or
T) with or without one base mismatch allowed. Of the 28
MKL-dependent genes, upstream sequences were availa-
ble for 20 genes in the DBTSS database while sequence
was extracted for 75 of the 122 MKL-independent genes.
There were 17 exact matches to the CArG box in these 95
serum inducible promoters (18%) (Table 5A). Given mul-
tiple matches in some genes this resulted in 11 genes
(12%) having exact matches. These frequencies were sim-
ilar in the MKL-independent and -dependent classes of
serum-inducible genes but significantly higher than the
frequencies found in searching the entire DBTSS collec-
tion of promoters as indicated by the p values in Table 5A.
The p value for the MKL-dependent promoters is high
because of the small sample size, however the frequency
of exact CArG box matches is similar to the other serum-
inducible genes.
We also searched for promoters with more than one CArG
box match since multiple SREs have been reported in
several SRF target genes and this could provide a mecha-
Table 4: List of genes induced by serum at 30, 60 or 120 minutes whose induction is MKL-dependent or -independent.
MKL-Dependent genes (28)
Known SRF target Genes Other Genes Other Genes
1 Jun-B 6 adrenomedullin 18 Adenosine A2b receptor
2 serum response factor 7 B-cell translocation gene 2 19 Coagulation factor III
3 fos-like antigen 1 8 CDC42 effector protein 3 20 Leukemia Inhibitory factor
4 tropomyosin 1, alpha 9 enigma homolog 21 Retinoblastoma inhibiting gene 1
5 vinculin 10 epiregulin 22 TGFβ inducible early growth response
11 hexokinase 2 23 Tribbles Homolog 1
12 inhibitor of DNA binding 3 24 Aortic alpha actin-2
13 interleukin 6 25 expressed sequence AA939927
14 pleckstrin homology-like 
domain, family A
26 transmembrane 4 superfamily member 10 
homolog
15 similar to Hs Mig6 27 methionine adenosyltransferase II, alpha
16 snail homolog 1 28 ELL-related RNA polymerase II, elongation 
factor
17 zyxin
MKL-Independent genes (122)
Known SRF target genes
1 cysteine rich protein 61 (Cyr61)
2 thrombospondin 1
3 FBJ osteosarcoma oncogene (c-fos)
4 FBJ osteosarcoma oncogene B (FosB)
5 cysteine rich protein 1 (Crp1)
6 prostaglandin-endoperoxide synthase 2
7 early growth response 1 (Egr1)
8 early growth response 2 (Egr2)BMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
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Correlation of microarray and real-time PCR data Figure 3
Correlation of microarray and real-time PCR data. The expression pattern of select serum-induced MKL-dependent 
and -independent genes was determined by quantitative real-time PCR (right) and compared to the microarray results (left) for 
the indicated genes. WT or DN-MKL1 cells were induced with serum for the indicated times before isolation of RNA. The 
results derived from the microarray hybridizations are the averages of triplicates while the real-time PCR measurements are 
the averages of at least duplicates ± the standard deviation.
Microarray Real-time PCR
0
1
2
3
4
5
6
7
8
9
0 30 60 120
0
1
2
3
4
5
6
7
8
0 30 60 120
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
SRF
B
C
0
0.5
1
1.5
2
2.5
3
3.5
0 30 60 120
0
2
4
6
8
10
12
0 30 60 120
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
Interleukin 6
Minutes
Minutes
Minutes
Minutes
Epiregulin
D
Jun B
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
0
5
10
15
20
25
30
35
40
0 30 60 120
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
0
2
4
6
8
10
12
14
16
0 30 60 120
A
Minutes Minutes
WT
DN
WT
DN
WT
DN
0
5
10
15
20
25
30
0 30 60 120
0
5
10
15
20
25
30
0 30 60 120
WT
DN
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
Minutes Minutes
0
10
20
30
40
50
60
70
80
0 30 60 120
0
5
10
15
20
25
30
35
40
45
50
0 30 60 120
Cyr61
E
0
5
10
15
20
25
03 0 6 0 120 0
10
20
30
40
50
60
0 30 60 120
Egr1
F
WT
DN
WT
DN
0
10
20
30
40
50
60
70
80
0 30 60 120 0
10
20
30
40
50
60
70
80
0 30 60 120
G
WT
DN
c-fos
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
Minutes
Minutes
Minutes
Minutes
Minutes
MinutesBMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
Page 9 of 15
(page number not for citation purposes)
nism to distinguish responses. While there were more
genes with greater than one CArG box match in the
serum-inducible genes than in the DBTSS promoters, the
numbers of MKL-independent vs. -dependent genes with
greater than one match were too low to show a statistical
significance (Table 5A).
The search for SRF binding sites allowing a one base mis-
match was more problematic since there were a high rate
of matches in the DBTSS data set, an average of .98 hits per
gene (Table 5B). There was not a significant increase in
this rate in the MKL-independent promoters, however
there was an increase in the MKL-dependent promoters to
1.55 hits per gene which was found to be statistically
significant (p = 0.005; Table 5B). This difference in the
MKL-dependent set was also apparent when considering
the increased frequency of genes with matches and of
genes with greater than one match (Table 5B).
The increased frequency of the exact CArG box sequence
in the upstream region of many of the MKL-dependent
genes gives further confidence that SRF coordinately regu-
lates many immediate early genes. However, the absence
of a CArG box does not preclude a gene from being a
direct target due to the flexibility of enhancer positioning.
The regulatory site may be upstream or downstream of the
1200 bp we have analyzed. For instance, in the case of the
jun B gene it has been shown that a CArG box down-
stream of the gene mediates its response to serum [33]. In
addition not all SRF target sites are perfect CArG boxes.
Known CArG boxes in serum inducible genes Figure 4
Known CArG boxes in serum inducible genes. The upper panel lists the positions and sequences of the known CArG 
boxes of the MKL-dependent or -independent genes. The bases that differ from the CArG box consensus sequence are in 
bold. The bottom panel shows the multilevel consensus sequence that was derived from each of these groups of CArG boxes. 
Below the consensus sequence is the simplified position-specific probability matrix that specifies the probability of each possi-
ble base appearing at each position in an occurrence of the motif multiplied by 10. 'a' denotes a probability that is almost or 
equal to 1. The consensus sequence is the best match to the CArG boxes oriented on either strand.
MKL DEPENDENT - Known
Name Position CArG box
junB +2084/+2093CCATATATGG
srf -43/-34 CCATAAAAGG
-63/-54 CCATATAAGG
fos-like antigen 1 -270/-261 CCATGTATGG
tropomyosin 1 alpha -86/-77 CCAAAAAAGT
vinculin -253/-244 CCTTATAAGG
MKL INDEPENDENT - Known
Name Position CArG Box
cyr 61 -1920/-1929 CCAAATATGG
thrombospondin 1 -1273/-1282 CCTTATTTGG
c-fos -307/-298 CCATATTAGG
fos b -428/-419 CCTTATATGG
crp1 intronic CCATGTATGG
cyclooxygenase 1 -1610/-1601 CCATAAATGG
egr1 -27/-18 CCATATATGG
-49/-40 CCATATTAGG
-351/-342 CCTTATATGG
-297/-288 CCATATAAGG
egr2  -68/-59 CCTTTTTTGG
+235/+244 CCATATATGG
CCATATAAGG
AT
A 82a3a7
Ca a 2
Ga 8
T 2 8532
CCATATAAGG
AT
Aa 3 a 2 8 6
Ca a 1
Ga a
T8 8 2 4
Multilevel Consensus SequenceBMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
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Several of the known SRF target sites contain single base
changes (Fig. 4). While our search allowing a single mis-
match resulted in an overly high frequency of matches,
there was a significantly higher rate of matches in the
MKL-dependent promoters suggesting that many of these
sites may be used as direct SRF targets.
We compared the CArG boxes more closely since previous
work with altered SREs suggested that changes in the A/T
core of the SRF can affect sensitivity to the TCF-independ-
ent (i.e. RhoA-MKL) pathway [34]. The known CArG
boxes were aligned from each class of genes, either MKL-
dependent or -independent (Fig. 4). We chose not to ana-
lyze the predicted CArG boxes since there were few exact
matches in the MKL-dependent promoters and because
there was too high a rate of matches allowing one mis-
match such that many of the matches are likely false pos-
itives. The MEME motif discovery tool (see Methods) was
used to arrive at a multilevel consensus sequence based on
a position specific probability matrix. The matrix specifies
the probability of each possible letter appearing at each
position in an occurrence of the motif. MEME also takes
into account both orientations of the sequence to arrive at
the consensus sequence. The consensus sequences for the
two sets are quite similar although there are some minor
differences and the sample size is relatively small.
We have compared the sequences of the known SRF target
genes to determine whether flanking sequences can
explain the differential sensitivity to DN-MKL1. We first
compared sequence flanking the known CArG boxes. The
MEME motif discovery tool was used to identify common
elements in 30 bp flanking each side of the CArG boxes.
There were no statistically significant matches in the
sequences from MKL-dependent of -independent genes.
We might have expected to see a TCF site, however this site
is very short and flexible. TCF binds to a short site near an
SRE and its binding is stabilized by binding to SRF. A
Table 5: Search of MKL-dependent and -independent serum-inducible promoters for SRF binding sites.
A. Exact matches to CArG box
genes in 
micro-
array
genes in 
DBTSS
matches frequency p genes 
with 
matches
frequency p genes w. 
>1 
matches
frequency p
Total 
genes
14824 6875 419 0.061 401 0.058 15 0.002
All 
Serum-
inducible
150 95 17 0.179 0.0001 11 0.116 0.0218 3 0.032 0.0010
MKL-
indep, 
serum-
inducible
122 75 14 0.187 0.0002 9 0.120 0.0293 2 0.027 0.0101
MKL-dep, 
serum-
inducible
28 20 3 0.150 0.1193 2 0.100 0.3245 1 0.050 0.0392
B. Matches to CArG box allowing one base mismatch
Total 
genes
14824 6875 6707 0.98 4230 0.615 1744 0.254
All 
Serum-
inducible
150 95 103 1.08 0.155 63 0.663 0.1958 25 0.263 0.4576
MKL-
indep, 
serum-
inducible
122 75 72 0.96 0.839 47 0.627 0.4682 15 0.200 0.8886
MKL-dep, 
serum-
inducible
28 20 31 1.55 0.005 16 0.800 0.0666 10 0.500 0.0155
The promoters from indicated groups were searched for exact matches with the CArG box sequence CC(A/T)6GG (A) or allowing for one base 
mismatch (B). Frequency indicates the number of matches divided by the number of DBTSS genes in each category. The p values were calculated 
based on a binomial distribution except for the value for matches in (B) (column 6 from the left) where the numbers were too large and the Poisson 
distribution of the frequency of matches per base was used.BMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
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consensus of (C/A)(C/A)GGA(A/T) was found, however
the orientation and position relative to the SRE was flexi-
ble and only the GGA sequence was absolutely required
[35]. Visual inspection of the flanking sequence to the
known CArG boxes suggested a potential TCF site in all of
the sequences except for that of cyr61.
We used two methods to compare the full promoter
sequences of the MKL-dependent and -independent,
serum-inducible genes for common elements that might
be required for their induction. We first used the MEME
tool to compare the promoters (-1000 to +200) derived
from the DBTSS database. As in Table 4, 20 MKL-depend-
ent promoter sequences and 75 MKL-independent pro-
moter sequences were extracted. The MEME tool could
only compare 50 of these promoters at a time such that 50
MKL-independent promoters and 50 random promoters
were compared. While MEME identified some common
elements within each of these three classes of promoters,
none of the elements identified among the MKL-depend-
ent of -independent promoters appeared to be specific
since similar elements were identified in the random pro-
moter set.
A second method we used was to look for common regu-
latory elements was oligonucleotide analysis which has
been used in yeast to identify regulatory sites [36]. This
method looks for enriched oligonucleotide frequencies in
a group of genes. We used the entire set of 6875 DBTSS
mouse promoter sequences to calculate the expected back-
ground frequencies of hexamers. The most specific
matches we found were in the set of 75 MKL-independent
promoters. The related oligonucleotides GGAGGG, CCG-
GAG and CGGAGA were enriched with significance
values (E-value) of 1.4 × 10-4 to 6.9 × 10-3. These oligonu-
cleotides were not enriched in a test case of 60 random
promoter sequences. The related sequence GGGAGG,
however, was similarly enriched in the MKL-dependent
promoters albeit with less statistical significance (E = 0.8).
It is intriguing that these oligonucleotides are similar to
the TCF consensus binding site (C/A)(C/A)GGA(A/T).
The most significantly enriched oligonucleotide in the 20
MKL-dependent promoters was CCGCGC with an E value
of 0.078. This lower significance may partially reflect the
smaller size of this data set but also may reflect the lower
significance of this enrichment. Given the relatively small
number of serum inducible genes and present computa-
tional tools, it appears that more careful experimental
mapping of the sequence elements in MKL-dependent
and -independent genes will be required to identify the
elements that determine their sensitivity to the MKL
pathway.
Discussion
Serum inducible genes have far ranging effects in many
physiological processes such as proliferation, wound heal-
ing, migration, and tissue remodeling [37]. SRF has been
implicated in the expression of many serum inducible
genes, particularly immediate early transcription factors,
but is also required for the expression of many muscle-
specific genes [31]. SRF is activated by different co-activa-
tors to control its diverse set of target genes in different tis-
sues [27,38-45]. Here, we have elucidated the target genes
that are dependent on one particular SRF co-activator
family – the MKL family. Since dominant negative MKL1
can block activation by all of the members of the MKL
family, MKL1 and 2, as well as myocardin (unpublished
data)[21,24], we have used cell lines expressing dominant
negative MKL1 to determine the role of the MKL family in
serum-induced gene expression patterns.
Cluster analysis of the microarray data identified different
classes of genes that showed significant variation across
the samples. Two classes of genes were either constitu-
tively activated or constitutively repressed. These could be
indirect targets of the SRF-MKL pathway or could suggest
functions for MKL apart from its role as a transcriptional
co-activator of SRF.
Among the serum inducible genes, we identified a signifi-
cant fraction, 28 of 150, that are MKL-dependent. This is
not to say that the other 122 genes may not be sensitive to
MKL under certain conditions. Rather, they must at least
have additional mechanisms for serum induction in
NIH3T3 cells. c-fos was identified as an MKL-independent
gene although we previously found by RNase protection
that its induction was significantly reduced in cells
induced with serum for 60 minutes [24]. We did observe
a small decrease in c-fos expression in our microarray
experiments, consistent with the RNase protection results,
however it did not pass our stringent statistical criteria for
MKL-dependence. Serum induction of some of the MKL-
independent immediate early genes may also be inde-
pendent of SRF. For example, the c-jun gene utilizes other
sequence elements for serum induction [46]. The TCF fac-
tors, elk-1, SAP1 and SAP2, are the main candidates
besides MKL factors for mediating serum induction of SRF
target genes. Further expression profiling will be required
with inhibitors of the SRF and TCF pathways to better
characterize the pathways used by the 150 serum induci-
ble genes described here.
Many of the serum-inducible genes identified here have
been previously described as immediate early genes either
as single genes or in microarray experiments [37,47,48].
The groups of genes include immediate early transcription
factors and cytokines, as previously noted [37], but also a
broad array of other types of genes. SRF null mice die inBMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
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utero due to the defective formation of a mesodermal
layer and SRF null ES cells are defective in focal adhesion
and migration [49,50]. We have also observed that the
DN-MKL1 cell line is significantly less adherent than the
control line (unpublished data). It is therefore interesting
that a number of our serum inducible genes are involved
in cytoskeletal structure and adhesion. These include vin-
culin, tropomyosin, zyxin, thrombospondin, tenascin,
integrin  α5, and transgelin. It will be interesting to
determine whether lowered expression of these genes in
SRF or MKL deficient cells leads to the changes in their
adhesive properties. Of these proteins, only vinculin is a
previously known MKL and SRF target gene [19,21,51].
Our microarray analysis found that zyxin is also an MKL-
dependent gene and zyxin expression was previously
found to be decreased in SRF null cells [50].
Sequences required for MKL-dependent and -independent 
genes
We analyzed the promoter sequences of the MKL-depend-
ent and -independent genes to identify elements that
might determine this sensitivity. Exact matches to a
simple CArG box consensus, CC(A/T)6GG, resulted in
matches in only about 12% of the serum-inducible genes
with similar proportions in the MKL-dependent and -
independent classes. While some functional SRF binding
sites contain a single base mismatch to the consensus, a
broader search for CArG boxes allowing a mismatch
resulted in a high number of matches in a broad promoter
database. There was a modest, statistically significant
increase in the matches in the MKL-dependent promoters
suggesting that some of these sites are real SRF targets.
Other SRF target sites may lie outside of the promoter
regions we have searched (-1000 to +200). This still leaves
the possibility that induction of many of the immediate
early genes is independent of SRF such as we have found
for the c-jun gene [46]. Microarray analysis of serum-
inducible genes with inhibition of SRF activity is required
to show which genes are SRF dependent.
Possible mechanisms for determining sensitivity to MKL
are the sequence of the CArG box, flanking sequence or
the context of other promoter elements. Our comparison
of the known CArG boxes from MKL-dependent and -
independent promoters did not show a strong difference.
Similarly we were not able to identify differences in the
flanking sequence. Analysis of the more full promoter
sequences has also not yielded clear common regulatory
elements to date. One set of oligonucleotides, containing
the sequence GGAG, was found in both the MKL-depend-
ent and -independent promoters at a significantly higher
frequency than in the full promoter database. The signifi-
cance of these sites remains to be determined though it is
notable that they are similar to the TCF consensus site.
One possible mechanism for distinguishing MKL target
genes is the presence of a TCF site next to a CArG box. This
would allow for TCF binding and activation by a MAP
kinase pathway instead of the MKL pathway. Since the
binding sites for TCF and MKL on SRF are similar [23],
TCF binding could preclude MKL activation. In fact, muta-
tion of the TCF site in the c-fos promoter allows it to be
activated by a serum induced, actin filament-dependent
pathway presumably through RhoA and MKL [20]. In
addition, we found that mutation of the TCF site in the c-
fos SRE results in significantly higher activation by MKL1
(Bo Cen and R.P., unpublished results). Nevertheless, c-
fos SRE elements with TCF sites are still activated by MKL1
and myocardin [21,27] such that there may be additional
elements that determine sensitivity to MKL1 activation.
Chromatin immunoprecipitation experiments have
shown that MKL1 can bind to the SRF, vinculin and cyr61
promoters in cells treated with the actin inhibitor swin-
holide A [23]. This is consistent with our identification of
SRF and vinculin as MKL target genes, but we found that
induction of cyr61 was MKL-independent. It is possible
that this difference is due to our inducing with serum
rather than swinholide A, since serum will induce alterna-
tive pathways such as the MAP kinase pathway. Chroma-
tin immunprecipitations showed that the TCF factor SAP1
bound to the egr1 promoter, possibly explaining its inde-
pendence of MKL, but no binding of SAP1 was observed
for two other MKL1-independent genes egr-1 and cyr61
[23]. Thus, TCF binding may not always explain the lack
of requirement for MKL factors.
Conclusions
Our results indicate that a subset of serum inducible genes
is dependent upon the MKL family for its induction. This
genomic classification of MKL-dependent and -independ-
ent serum-inducible genes is a significant step for charac-
terizing which pathways are required for induction of
each cellular immediate early gene.
Methods
Gene expression analysis
NIH3T3 cells stably expressing dominant negative MKL1
(a.a. 1-630)(DN-MKL1) or containing the vector, pBa-
bePuro, were previously described [21]. The cells were
serum starved in Dulbecco's modified Eagle's medium
(DMEM) with 0.2% new born calf serum (NCS) for 24
hours and then induced with 20% NCS for 30, 60 and 120
minutes. Total RNA from these cells was prepared using
Trizol (Invitrogen) and then purified using RNeasy col-
umns (Qiagen). Total RNA (8 µg) was used for first-strand
cDNA synthesis using T7-Oligo-dT primers and Power-
script reverse transcriptase (Invitrogen) for 1 hour at
42°C. This was followed by second-strand synthesis for 2
hours at 16°C using RNase H, E. coli DNA polymerase I,BMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
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and E. coli DNA ligase (Invitrogen). The obtained double-
stranded cDNA was then blunted by the addition of 20
units T4 DNA polymerase and incubation for 5 min at
16°C. The material was then purified by phenol:chloro-
form:isoamyl alcohol extraction followed by precipitation
with ammonium acetate and ethanol. The cDNA was then
used in an in vitro transcription reaction for 6 hours at
37°C using a T7 in vitro transcription kit (Affymetrix) and
biotin-labeled ribonucleotides. The obtained cRNA was
purified on an RNeasy column. The eluted cRNA was then
fragmented by incubation of the products for 30 min in
fragmentation buffer (40 mM Tris-acetate, pH 8.1, 100
mM KOAc, 30 mM MgOAc) at 95°C. The fragmented
labeled RNA (15 µg) was hybridized to an Affymetrix
mouse MOE430A Genechip at 45°C according to the
manufacturer's protocol [52] and stained with streptavi-
din-phycoerythrin. The chips were then scanned with an
Affymetrix Genechip Scanner GS300. All the data sets
were done in triplicates from serum stimulation of cells to
scanning of the microarrays.
The percent of genes with significant expression
("present" calls) ranged from 50.4 to 56.5% for each
microarray. The 3':5' ratio for a control actin gene ranged
from 1.0 to 1.31 for each of the 24 microarrays scanned.
The scaling factor to account for differences in probe
labeling and general changes in hybridization in each
microarray was scaled to a target intensity of 250 (using
Affymetrix Microarray Suite 5.0 software) and ranged
from 1.273–5.542.
dChip analysis
The dChip software [30,53] was used for the normaliza-
tion and calculation of model based expression indexes
(MBEI) after pooling the replicate arrays and for the hier-
archical clustering analysis of the data from the Affymetrix
Gene chips. Normalization was based on a large set of
probes determined iteratively to be invariant across the
different microarrays. After normalization each array has
a similar overall signal [30]. The initial analysis was per-
formed using the perfect match (PM)-only model and
genes were filtered according to the criteria of a) co-effi-
cient of variation (standard deviation/mean) across the
eight conditions must be between 0.50 and 10.00, b) a
gene must be called 'Present' in ≥ 20% of the arrays used,
c) the variation of the standard deviation/mean for repli-
cate arrays for a single condition must be between 0 and
0.5, and d) the expression level must be >= 100 in at least
one of the time points. Hierarchical tree clusters were then
generated using this filtered gene list.
Expression values (MBEIs) at each time point were deter-
mined with a standard error of the mean. These values
were used to calculate the fold change with 90% confi-
dence intervals. The confidence intervals were derived
from the standard errors and fold changes based on a χ2
distribution model with one degree of freedom [30]. For
the lists of serum inducible genes the low confidence
interval value was required to be greater than two. For the
inhibition in the DN-MKL cells, the low confidence inter-
val value was required to be at least 35% less than in the
WT cells for the gene to be designated MKL-dependent.
Real time PCR
Total RNA was isolated from the DN-MKL1 and vector
containing NIH3T3 cells as described for the microarray
analysis and 1 µg was used for first strand cDNA synthesis
(Powerscript Reverse Transcriptase, BD Biosciences) using
oligo-dT primers according to the manufacturer's proto-
cols. One fiftieth of the reverse transcription reaction was
included in a 20 µl PCR reaction. For a quantitative anal-
ysis, SYBR green PCR technology was used (Applied Bio-
systems). Real-time detection of the PCR product was
monitored by measuring the increase in fluorescence
caused by the binding of SYBR green to double-stranded
DNA with an ABI PRISM 7000 Sequence Detector. To cal-
culate relative quantification values a threshold cycle (Ct),
the cycle at which a statistically significant increase in flu-
orescence occurs, was derived from the resulting PCR pro-
files of each sample. Ct is a measure of the amount of
template present in the starting reaction. To correct for dif-
ferent amounts of total cDNA in the starting reaction, Ct
values for an endogenous control (Acidic ribosomal phos-
phoprotein P0) were subtracted from those of the corre-
sponding sample, resulting in ∆Ct. The ∆Ct value of the
serum starved wt sample was chosen as the reference
point and was subtracted from the ∆Ct value of all the
other samples, resulting in ∆∆Ct. The relative quantifica-
tion value is expressed as 2-∆∆Ct giving the relative differ-
ence of the serum induced points compared to the serum-
starved cells for expression of a particular gene. All real
time PCR data sets shown are the results of two independ-
ent mRNA preparations and amplifications. Amplifica-
tion of only a single species in each PCR reaction was
determined by checking for a dissociation curve with a
single transition.
Promoter sequence analysis
The Database of Transcriptional Start Sites
(DBTSS)[32,54] was used to extract the promoter
sequences (-1000 to +200) of all the available full length
cDNAs and RefSeq entries based on the start site of the
cDNA as +1. This mouse data base was searched for SRF
binding sites using the consensus CCWWWWWWGG,
where W is A or T, with or without allowing for one base
mismatch.
The CArG box sequences of the known SRE regulated
genes were derived from the literature. The motif discov-
ery tool MEME (Multiple EM for Motif Elicitation) [55,56]BMC Molecular Biology 2004, 5:13 http://www.biomedcentral.com/1471-2199/5/13
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was then used to derive a multilevel consensus sequence
based on a position specific probability matrix. The matrix
specifies the probability of each possible nucleotide
appearing at each possible position in an occurrence of
the motif. MEME takes into account both orientations of
the sequence to arrive at the consensus sequence.
Sequences flanking the known SREs (30 bp on each side)
were extracted from Genbank and MEME was also used to
compare these sequences. A control set of 10 upstream
sequences from the same genes (70 bp in length) was also
searched for comparison.
Promoter sequences (-1000 to +200) of the serum induc-
ible genes were also searched for common elements with
MEME. Promoters for 20 MKL-dependent, 50 MKL-inde-
pendent and 50 random promoters were searched. These
promoter sequences were additionally searched by oligo-
nucleotide analysis for enriched hexamers [36,57] except
that 20 MKL-dependent and 75 MKL-independent were
searched. The background frequency of oligonucleotides
was set using promoter sequence (-1000 to +200) for all
6875 mouse promoters in DBTSS. A control searching 60
random promoters also did not show significant enrich-
ment of specific oligonucleotides.
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